Gushengtang Holdings Limited (02273.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

HKD 6.54B

MomentumView details →

1D Return

+1.10%

YTD Return

−2.27%

RSI (14)

50.0

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

5.7x

Market Cap

HKD 6.54B

RSI (14)

50.0

MomentumView details →

1D Return

+1.10%

YTD Return

−2.27%

ProfitabilityView details →

Gross Margin

30.78%

Net Margin

11.79%

EBITDA Margin

15.65%

ROE (TTM)

41.01%

ROA (TTM)

17.65%

Asset Turnover

1.56x

GrowthView details →

Revenue YoY

+41.79%

EPS YoY

+61.69%

FCF YoY

+24.60%

Revenue CAGR 3Y

+25.99%

EPS CAGR 3Y

+22.44%

EBITDA YoY

+79.00%

EarningsView details →

EPS (Actual)

HKD 0.80

EPS Surprise

−13.76%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

−13.76%

Rev Surprise

0.32%

Capital & dividendView details →

Debt/Equity

0.82x

Current Ratio

1.18x

Quick Ratio

1.06x

Div Yield

3.77%

Div Rate

HKD 1.04

Div Growth 1Y

−9.21%

Financials snapshotView financials →

Revenue (TTM)

6.54B

Net Income (TTM)

770.34M

Op. CF (TTM)

934.76M

Next earningsMar 31, 2027 →

Latest newsMore news →

Gushengtang (02273.HK) declared an interim dividend of HKD 1.15 per share for the six months ended June 2026, up approximately 2.29 times from HKD 0.35 in the same period last year.8d ago

Gushengtang announced its first-half 2026 results, with net profit of RMB 219 million, up 44.2% year-on-year.8d ago

Similar companies

Hygeia Healthcare Holdings Co., Limited06078.HK Chemed CorporationCHE Jinxin Fertility Group Limited01951.HK LifeStance Health Group, Inc.LFST The Ensign Group, Inc.ENSG Universal Health Services, Inc.UHS Find similar companies →

Latest newsMore news →

Gushengtang (02273.HK) declared an interim dividend of HKD 1.15 per share for the six months ended June 2026, up approximately 2.29 times from HKD 0.35 in the same period last year.8d ago Gushengtang announced its first-half 2026 results, with net profit of RMB 219 million, up 44.2% year-on-year.8d ago Gushengtang announced the acquisition of 100% equity in YC TCM SEGAR, YC TCM, and SWS Medical, Malaysian medical institutions providing traditional Chinese medicine consultation and treatment services.8d ago